科研之友
微信
新浪微博
Facebook
分享链接
摘要
Tau aggregation is a pathological hallmark of Alzheimer's disease, Parkinson's disease, and many other neurodegenerative disorders known as tauopathies. Tau aggregates take on many forms, and their formation is a multistage process with intermediate stages. Recently, tau oligomers have emerged as the pathogenic species in tauopathies and a possible mediator of amyloid-beta toxicity in Alzheimer's disease. Here, we use a novel, physiologically relevant method (oligomer cross-seeding) to prepare homogeneous populations of tau oligomers and characterize these oligomers in vitro. We show that both A beta and a-synuclein oligomers induce tau aggregation and the formation of beta-sheet-rich neurotoxic tau oligomers.
- 出版日期2010-11-30
